Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Steroid dehydrogenase deficiency-dental anomalies syndrome is an autosomal recessive liver disease which was associated with numerical dental aberrations in a consanguineous Arabi Saudi family. This association suggests that the same gene is involved in both defects. General hypomineralisation and enamel hypoplasia found in this family is thought to be secondary to malabsorption due to liver disease.
Features include very common findings: Abnormal dental enamel morphology, Hepatic failure, Enamel hypoplasia, and Supernumerary tooth.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 1 | Hepatic failure |
Biomarker and diagnostic research for steroid dehydrogenase deficiency-dental anomalies syndrome has been reported in the published literature.
Phenotype severity distribution: 4 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for steroid dehydrogenase deficiency-dental anomalies syndrome.
24 publications have been identified in PubMed for steroid dehydrogenase deficiency-dental anomalies syndrome. Research spans Basic Science / Preclinical (38%), Case Report / Case Series (29%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 9 | 38% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:40 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
7 |
29% |
Research summaries | 4 | 17% |
Disease patterns and progression | 3 | 13% |
Testing and diagnosis research | 1 | 4% |
Galli E (2026). [PMID: 41553539](https://pubmed.ncbi.nlm.nih.gov/41553539/). *Clin Exp Med*. [Epidemiology / Natural History]
Cherska M (2026). [PMID: 41759026](https://pubmed.ncbi.nlm.nih.gov/41759026/). *Wiad Lek*. [Review / Meta-Analysis]
Zha X (2026). [PMID: 41620040](https://pubmed.ncbi.nlm.nih.gov/41620040/). *J Steroid Biochem Mol Biol*. [Basic Science / Preclinical]
Ouyang X (2026). [PMID: 41580826](https://pubmed.ncbi.nlm.nih.gov/41580826/). *J Ovarian Res*. [Basic Science / Preclinical]
Zhang C (2026). [PMID: 42039121](https://pubmed.ncbi.nlm.nih.gov/42039121/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Sappl A (2026). [PMID: 42222075](https://pubmed.ncbi.nlm.nih.gov/42222075/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Hackl L (2025). [PMID: 40725494](https://pubmed.ncbi.nlm.nih.gov/40725494/). *Genes (Basel)*. [Case Report / Case Series]
Madalena IR (2025). [PMID: 40172435](https://pubmed.ncbi.nlm.nih.gov/40172435/). *Braz Oral Res*. [Diagnostic / Biomarker]
Shinzato T (2025). [PMID: 40090720](https://pubmed.ncbi.nlm.nih.gov/40090720/). *Intern Med*. [Case Report / Case Series]
Chen K (2025). [PMID: 40464756](https://pubmed.ncbi.nlm.nih.gov/40464756/). *J Dermatolog Treat*. [Case Report / Case Series]